Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FLGB9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,782
Award facts
- Contract value 100% obligated
- $4,782.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,782.48 on August 8, 2025, for the supply of Xolair 300 mg/2 mL auto-injector units. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by August 29, 2025, with fulfillment occurring at the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a substantial portfolio of federal medical supply contracts, predominantly with the Defense Logistics Agency and its Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare systems, veterans programs, and other government healthcare entities. This particular delivery order for Xolair, a specialized auto-injector medication, reflects the vendor's capability to fulfill federal medical procurement requirements for specialized pharmaceuticals through the broader DLA Pharmaceutical Prime Vendor Global Program framework.
Quick answers
Who was awarded contract SPE2DB25FLGB9?
SPE2DB25FLGB9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FLGB9 worth?
The government has obligated $4,782 on SPE2DB25FLGB9.
Is contract SPE2DB25FLGB9 an order under another contract?
Yes. SPE2DB25FLGB9 is a delivery order under SPE2DB22D1002, an indefinite delivery contract.
Was contract SPE2DB25FLGB9 competed?
The extent of competition for SPE2DB25FLGB9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award